Simply put, you are completely mistaken. Bacterial pneumonia should be treated with antibiotics, viral pneumonia won't benefit from antibiotics. But I guarantee that almost every small child with severe pneumonia of whatever cause will likely receive antibiotics early because its impossible to clinically rule out bacterial pneumonia, which may often supervene and coexist during during a viral respiratory infection. There is no such thing as "atopic" pneumonia. An experienced paediatrician in a less compromised child may hold off antibiotics in bronchiolitis or what seems to be a viral pneumonia and monitor the course over the first few hours. But cough analyis cannot possibly distinguish the causative agent.
Maybe it is you who needs to brush up on the medical aspects of repiratory diseases.
http://emedicine.medscape.com/article/300455-differential
Diagnosing respiratory disease which includes cancer, infections, foreign bodies, pulmonary fibrosis, obstructive airways disease, allergic (atopic) airways disease, autoimmune disease, congestive heart disease, pleural effusions and others requires a spectrum of tools which cannot be substituted with "cough analysis".
Good medical care is not unlike fault tracing in any other complex system like electronics, hydraulics or combustion engines. It requires checking the sub systems to isolate the probelm and then honing in on the faulty component.
To do this quickly and accurately requires good understanding of physiology and pathology and routines that do not skip steps - thoroughness is important to avoid overlooking something important, for instance the obstruction in an airway caused by cancer or a foreign body which in turn has caused pneumonia.
You should have figured out by you are arguing with a very experienced professional. I'm not trying to "down ramp" here. I am trying to give an honest, professional opinion about the value of this technology and where it might fit in the scheme of things.
It is one tool along with Chest X-rays, various types of MRI scans, Ultrasound scans, lung spirometry, blood gas analysis, microbiology, immunology, pathology, bronchoscopy and good old clinical skills of examination and history taking that allow an accurate diagnosis to be made. When steps get skipped in investigations, its not uncommon for basic things to get overlooked and the wrong diagnosis or interpretation made. Resapp is an addition to, not a substitute for other tools.
- Forums
- ASX - By Stock
- RAP
- Ann: Voluntary Suspension
Ann: Voluntary Suspension, page-224
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online